The effects of early short-term insulin treatment vs. glimepiride on beta cell function in newly diagnosed type 2 diabetes with HbA1c above 9
DISCUSSION: Early short-term insulin intervention in newly diagnosed T2D improves beta cell function more than glimepiride, both added to metformin, resulting in a superior and longer lasting glycemic and lipid control.PMID:37476884 | DOI:10.55730/1300-0144.5616
Source: Turkish Journal of Medical Sciences - Category: General Medicine Authors: Jelena Stojanovic Marina Andjelic-Jelic Miljanka Vuksanovic Milica Marjanovic-Petkovic Biljana Jojic Marko Stojanovic Teodora Beljic-Zivkovic Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | General Medicine | Glimepiride | Insulin | Metformin | Study | Turkey Health